From November 3, 2023 to December 7, 2023, the company has repurchased 1,550,900 shares, representing 0.38% for CNY 29.99 million. With this, the company has completed the repurchase of 1,550,900 shares, representing 0.38% for CNY 29.99 million under the buyback announced on November 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.19 CNY | -0.49% | -4.96% | -24.84% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.84% | 803M | |
+48.74% | 780B | |
+41.76% | 627B | |
+20.12% | 334B | |
+6.60% | 296B | |
+17.55% | 244B | |
-0.61% | 217B | |
+11.50% | 214B | |
+4.43% | 161B | |
-3.79% | 159B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 4, 2023.